← Browse by Condition
Medical Condition

heart failure nyha class ii

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for heart failure nyha class ii sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine 1 trial
Massachusetts General Hospital 1 trial
CVRx, Inc. 1 trial
NCT03180320
Recruiting

Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)

Enrollment
150 pts
Location
China
Sponsor
Guangdong Provincial Hospital ...
View Trial →
NCT04829617
Recruiting

Promoting Well-being and Health in Heart Failure

Enrollment
280 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07232030
Recruiting

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Enrollment
2,500 pts
Location
United States
Sponsor
CVRx, Inc.
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology